Molecular Instruments is Discovery Tools (Healthcare) in United States that focus on pharmaceutical companies business. Founded in 2018. They cover business area such as developer, molecular kit, quantitative bioimaging, drug development, academic research, clinical diagnostic, signal amplification, hybridization chain reaction, HCR, simple, robust, enzyme-free protocol, any organism, researcher, pharmaceutical company, image-base research.
2018
( 6 years old in 2024 )
Pharmaceutical Companies
-
5015 Eagle Rock Boulevard
Suite 301
Los Angeles, CA 90041
United States
Private
developermolecular kitquantitative bioimagingdrug developmentacademic researchclinical diagnosticsignal amplificationhybridization chain reactionHCRsimple, robust, enzyme-free protocolany organismresearcherpharmaceutical companyimage-base research
* We use standard office opening hours in near Molecular Instruments's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Molecular Instruments is Discovery Tools (Healthcare) business from United States that founded in 2018 (6 years old in 2024), Molecular Instruments business is focusing on Pharmaceutical Companies.
Molecular Instruments headquarter office and corporate office address is located in 5015 Eagle Rock Boulevard Suite 301 Los Angeles, CA 90041 United States.
Molecular Instruments was founded in United States.
In 2024, Molecular Instruments is currently focus on pharmaceutical companies sector.
Above is snippet of Google Trends for "pharmaceutical companies" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Molecular Instruments, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
